ArticleCancer medicine2024

Efficacy and safety of PD-1 monoclonal antibody combined with interferon-alpha 1b and anlotinib hydrochloride as the second-line therapy in patients with unresectable advanced melanoma: A retrospective study.

Bolun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.